Integrase inhibitors (INIs) are the most new class of antiretroviral medications to be approved to treat HIV infection. They are quickly becoming standard treatments for both HIV naive and substantially pre-treated patients.
This report contains market size and forecasts of Integrase Inhibitors in global, including the following market information:
Global Integrase Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Integrase Inhibitors Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Integrase Inhibitors companies in 2021 (%)
The global Integrase Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Raltegravir Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Integrase Inhibitors include Merck, GlaxoSmithKline, Hetero Drugs, Mylan, Aurobindo Pharma, Cipla, Laurus Labs, Gilead Sciences and Micro Labs. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Integrase Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Integrase Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Integrase Inhibitors Market Segment Percentages, by Type, 2021 (%)
Raltegravir
Dolutegravir
Elvitegravir
Bictegravir
Global Integrase Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Integrase Inhibitors Market Segment Percentages, by Application, 2021 (%)
Clinic
Hospital
Global Integrase Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Integrase Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Integrase Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Integrase Inhibitors revenues share in global market, 2021 (%)
Key companies Integrase Inhibitors sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Integrase Inhibitors sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GlaxoSmithKline
Hetero Drugs
Mylan
Aurobindo Pharma
Cipla
Laurus Labs
Gilead Sciences
Micro Labs